Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist.

Autor: M, Sarau H, E, Griswold D, B, Bush, W, Potts, P, Sandhu, D, Lundberg, J, Foley J, B, Schmidt D, F, Webb E, D, Martin L, J, Legos J, G, Whitmore R, C, Barone F, D, Medhurst A, A, Luttmann M, A, Giardina G, W, Hay D

Publikováno v: The Journal of Pharmacology and Experimental Therapeutics; October 2000, Vol. 295 Issue: 1 p373-81, 9p

SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo.

Autor: E, Griswold D, F, Webb E, M, Badger A, D, Gorycki P, A, Levandoski P, A, Barnette M, M, Grous, S, Christensen, J, Torphy T

Publikováno v: The Journal of Pharmacology and Experimental Therapeutics; November 1998, Vol. 287 Issue: 2 p705-11, 7p